QGEN – Qiagen N.V.
Qiagen N.V.QGEN
$43.57Name : Qiagen N.V.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $9,683,171,328.00
EPSttm : 0.34
Qiagen N.V.
$43.57
0.07%$0.03Fair Value
52.62
Margin Of Safety %
21
Put/Call OI Ratio
0.83
Float Short %
1.58
EPS 1 Diff
0.05
EPS Year Diff
0.59
Ticker: QGEN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-09-06 | QGEN | 44.49 | 0.85 | 0.13 | 15636 |
| 2024-09-09 | QGEN | 45.715 | 0.85 | 2.70 | 15649 |
| 2024-09-10 | QGEN | 45.91 | 0.86 | 3.11 | 16301 |
| 2024-09-11 | QGEN | 45.84 | 0.88 | 2.56 | 16578 |
| 2024-09-12 | QGEN | 45.56 | 0.88 | 0.82 | 17274 |
| 2024-09-13 | QGEN | 46.38 | 0.88 | 0.48 | 17358 |
| 2024-09-16 | QGEN | 46.57 | 0.88 | 4.89 | 17382 |
| 2024-09-17 | QGEN | 45.65 | 0.89 | 3.62 | 17455 |
| 2024-09-18 | QGEN | 45.69 | 0.98 | 0.00 | 18758 |
| 2024-09-19 | QGEN | 45.6 | 0.98 | 1.03 | 18760 |
| 2024-09-20 | QGEN | 44.91 | 0.98 | 1.34 | 19479 |
| 2024-09-23 | QGEN | 44.3 | 0.87 | 0.04 | 12624 |
| 2024-09-24 | QGEN | 44.88 | 0.86 | 0.36 | 12675 |
| 2024-09-25 | QGEN | 44.11 | 0.84 | 0.17 | 13621 |
| 2024-09-26 | QGEN | 45.03 | 0.94 | 0.00 | 14377 |
| 2024-09-27 | QGEN | 45.23 | 0.94 | 0.10 | 14375 |
| 2024-09-30 | QGEN | 45.57 | 0.94 | 0.06 | 14397 |
| 2024-10-01 | QGEN | 44.92 | 0.94 | 4.31 | 14422 |
| 2024-10-02 | QGEN | 44.34 | 0.97 | 0.11 | 14743 |
| 2024-10-03 | QGEN | 43.55 | 0.97 | 0.00 | 14747 |
| 2024-10-04 | QGEN | 43.56 | 0.83 | 0.04 | 16056 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-09-06 | QGEN | 44.49 | 5.9 | 455.1 | 2.14 |
| 2024-09-09 | QGEN | 45.89 | 5.9 | 473.1 | 2.14 |
| 2024-09-10 | QGEN | 45.90 | 5.9 | 455.2 | 2.14 |
| 2024-09-11 | QGEN | 45.85 | 5.9 | 454.4 | 2.14 |
| 2024-09-12 | QGEN | 45.55 | 5.9 | 451.4 | 2.14 |
| 2024-09-13 | QGEN | 46.36 | 5.9 | 464.9 | 2.14 |
| 2024-09-16 | QGEN | 46.58 | 5.9 | 457.8 | 2.14 |
| 2024-09-17 | QGEN | 45.67 | 5.9 | 443.9 | 2.14 |
| 2024-09-18 | QGEN | 45.65 | 5.9 | 454.9 | 2.14 |
| 2024-09-19 | QGEN | 45.60 | 5.9 | 454.1 | 2.14 |
| 2024-09-20 | QGEN | 44.91 | 5.9 | 446.6 | 2.14 |
| 2024-09-23 | QGEN | 44.46 | 5.9 | 449.4 | 2.14 |
| 2024-09-24 | QGEN | 44.87 | 5.9 | 460.2 | 2.14 |
| 2024-09-25 | QGEN | 44.12 | 5.9 | 445.6 | 2.14 |
| 2024-09-26 | QGEN | 45.02 | 5.9 | 466.8 | 2.14 |
| 2024-09-27 | QGEN | 45.24 | 5.9 | 457.8 | 2.14 |
| 2024-09-30 | QGEN | 45.55 | 5.9 | 459.0 | 2.14 |
| 2024-10-01 | QGEN | 44.91 | 5.9 | 446.8 | 2.14 |
| 2024-10-02 | QGEN | 44.35 | 5.9 | 447.9 | 2.14 |
| 2024-10-03 | QGEN | 43.55 | 5.9 | 444.8 | 2.14 |
| 2024-10-04 | QGEN | 43.56 | 5.9 | 455.3 | 2.14 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-09-06 | QGEN | 0.00 | 0.59 | 1.46 |
| 2024-09-09 | QGEN | 0.00 | 0.59 | 1.46 |
| 2024-09-10 | QGEN | 0.00 | 0.59 | 1.46 |
| 2024-09-11 | QGEN | 0.00 | 0.59 | 1.46 |
| 2024-09-12 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-13 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-16 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-17 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-18 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-19 | QGEN | 0.00 | 0.59 | 1.34 |
| 2024-09-20 | QGEN | 0.00 | 0.59 | 1.35 |
| 2024-09-23 | QGEN | 0.00 | 0.59 | 1.35 |
| 2024-09-24 | QGEN | 0.00 | 0.59 | 1.35 |
| 2024-09-25 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-09-26 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-09-27 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-09-30 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-10-01 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-10-02 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-10-03 | QGEN | 0.00 | 0.59 | 1.58 |
| 2024-10-04 | QGEN | 0.00 | 0.59 | 1.58 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.55
Avg. EPS Est. Current Quarter
0.54
Avg. EPS Est. Next Quarter
0.6
Insider Transactions
Institutional Transactions
0.59
Beta
0.4
Average Sales Estimate Current Quarter
492
Average Sales Estimate Next Quarter
526
Fair Value (Academic)
51.32
Quality Score
65
Growth Score
68
Sentiment Score
78
Actual DrawDown %
28.4
Max Drawdown 5-Year %
-37.4
Target Price
51.98
P/E
138.85
Forward P/E
19.02
PEG
21.59
P/S
4.98
P/B
2.84
P/Free Cash Flow
23.37
EPS
0.31
Average EPS Est. Cur. Y
2.14
EPS Next Y. (Est.)
2.28
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
3.75
Relative Volume
0.68
Return on Equity vs Sector %
-19.5
Return on Equity vs Industry %
-8.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
455.3
Qiagen N.V.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 5900
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids from secondary sample materials; and instruments for nucleic acid purification and accessories. It also provides interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants, such as mutations, insertions, deletions, and fusions; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. In addition, it offers PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination; PCR instruments include digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It also offers predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification; QIAGEN consumables and instruments, as well as bioinformatics solutions; and custom laboratory and genomic services. It serves molecular diagnostics, academia, pharmaceutical, and applied testing customers. It has a collaboration with the U.S. FBI; and with Bio-Manguinhos/Fiocruz to detect malaria and dengue. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
stock quote shares QGEN – Qiagen N.V. Stock Price stock today
news today QGEN – Qiagen N.V. stock forecast ,stock prediction 2023 2024 2025
marketwatch QGEN – Qiagen N.V. yahoo finance google finance
stock history QGEN – Qiagen N.V. invest stock market
stock prices QGEN premarket after hours
ticker QGEN fair value insiders trading